Clinical trial / 2017
A replacement diet with organic ancient khorasan wheat improved metabolic and inflammatory risk factors in type 2 diabetes patients.
In a randomized, double-blinded crossover trial, 21 patients with type 2 diabetes consumed products made from organic ancient khorasan wheat or modern organic control wheat for 8 weeks each, separated by an 8-week washout. The metabolic risk profile improved only after the khorasan intervention, with mean reductions in total cholesterol (-3.7%), LDL cholesterol (-3.4%), insulin (-16.3%), and blood glucose (-9.1%). Khorasan wheat also significantly reduced reactive oxygen species, VEGF, and interleukin-1ra, and increased total antioxidant capacity (+6.3%), whereas modern wheat produced no significant differences from baseline.
- Study type
- Randomized, double-blinded crossover trial
- Who was studied
- 21 patients with type 2 diabetes (14 females, 7 males)
- What was measured
- Glucose, insulin, lipid, inflammatory markers, and redox balance
THE PAPER
A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial.
Whittaker A, Dinu M, Cesari F, Gori AM, Fiorillo C, Becatti M, Casini A, Marcucci R, Benedettelli S, Sofi F. Eur J Nutr, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.